TABLE 1

Patient Characteristics

Patient no.	Sex	Age (y)	Year of diagnosis	Initial pathologic stage	Surgery	Other therapy	Type of cancer	Calcitonin (ng/mL) at time of PET	CEA (ng/mL) at time of PET	Flush/diarrhea	Results of PET confirmed by	Follow-up (mo)
1	M	60	1995	pT4 pNX MX	BS ST	RN, irrad	Spor	298.00	9.4	−	—	62
2	F	46	1996	pT3 pN0 MX	NT, BS LND	Irrad	Spor	311.00	112.9	+	—	59
3	M	42	1998	pT3 N1b MX	ST, C LNP	Irrad	Spor	1,070.00	5.2	−	Patho	24
4	F	44	1997	pT4 N1a MX	NT, L LND	Irrad	Spor	3,574.00	31.7	−	Radi	42
5	F	25	1998	pT2 pN1a MX	ST, 2 R LNP	Irrad	MEN 2a	5,827.00	7.9	+	Patho	33
6	M	29	1998	pT3 pN1b MX	TT, BS LND + Sc + C	Irrad	ND	4,209.00	353.0	+	Radi	24
7	F	43	1995	pT2 pN1a M0	NT, BS LND	Irrad	MEN 2a	21.00	0.7	−	—	70
8	M	47	1985	pT3 pN1a M0	R NT	Chemo	ND	1,880.00	399.4	+	Patho	187
9	M	54	1998	pT2 pN1b M0	NT, L LND + C	Irrad	MEN 2b	32.00	2.2	−	—	32
10	F	59	1992	pT3 pNX M0	ST	NP	Spor	826.00	0.5	−	Patho	105
11	F	47	1994	pT1 pNX M0	ST	NP	FMTC	18.70	0.6	−	—	72
12	F	46	1994	pT2 pN1a M0	ST, R LND	RN, irrad	Spor	211.00	401.3	−	Patho	78
13	M	67	1999	pT2 pN1a MX	TT, R LND + Sc	Irrad	Spor	1,627.00	6.5	+	Radi	20
14	F	56	1989	pT2 pNX M0	ST	RN, irrad	FMTC	131.00	5.4	−	Radi	133
15	M	21	1998	pT3 pN1b MX	NT, R LND + Medi	Chemo, irrad	ND	3,954.00	207.3	+	Radi	35
16	F	51	1969	pT3 pN1a M0	ST, L LNP	Irrad	MEN 2a	14.50	8.7	−	—	379
17	F	41	1997	pT4 pNX M0	Sternotomy	Irrad	MEN 2a	1,631.00	157.9	−	Patho	38
18	M	23	1997	pT1 pN1b MX	TT, BS LND	Irrad	MEN 2b	526.00	7.9	−	Patho	40
19	F	60	1983	pT3 pN0 MX	ST, R LND	RN	Spor	1,396.00	22.9	−	Radi	208
20	M	58	1998	pT2 pN1a MX	NT, R LND	Irrad	Spor	91.00	14.7	−	Radi	33
21	M	40	1993	pT1 pN1a MX	NT, L LND	RN, irrad	ND	521.00	3.3	−	Radi	92
22	F	41	1998	pT2 pNX MX	NT	NP	Spor	40.20	0.5	−	—	33
23	F	69	1992	pT2 pN1a M0	NT, R LND	RN, irrad	Spor	999.00	6.9	−	—	97
24	M	38	1990	pT2 pN1a MX	TT, L LND	Irrad	ND	240.00	7.4	−	Patho	128
25	F	49	1997	pT2 pNX MX	NT	Irrad	Spor	379.00	5.7	−	Radi	41
26	F	62	1979	pT3 pN1a MX	NT, L LND	Chemo, irrad	Spor	2,500.00	105.0	−	Radi	255
27	M	52	1999	pT3 pNX MX	NT	NP	FMTC	2,844.00	694.5	+	Patho	21
28	M	48	1999	pT2 pN0 M0	TT, BS LND	NP	MEN 2a	24.00	1.9	−	—	20
29	M	46	1994	pT2 pNX M0	ST, L LND	Irrad	FMTC	2,213.00	11.4	−	Patho	58 (death)
30	M	34	1994	pT2 pN1b MX	ST, L LND + Sc + C	RN, irrad	MEN 2a	584.00	37.9	−	Radi	72
31	F	50	1990	pT3 pNX MX	TT, Medi	Irrad	ND	3,974.00	31.9	−	Radi	127
32	F	55	1990	pT2 pNX MX	NT	NP	Spor	56.00	0.1	+	Radi	129
33	F	45	1999	pT1 pN0 M0	ST, L LNP	NP	Spor	21.50	1.2	−	—	17
34	F	54	1984	pT2 pN1a M0	NT, L LND	Irrad	Spor	326.00	5.7	−	Radi	199
35	F	66	1997	pT3 pN0 M0	TT, BS LND	Irrad	MEN 2a	279.00	2.3	−	—	38
36	M	48	1997	pT4 pN1b MX	NT, R LND + Sc + C	Irrad	Spor	3,496.00	277.1	−	—	46
37	M	66	1997	pT2 pN1b MX	NT, R LND + C	Irrad	Spor	2,692.00	54.4	−	Radi	36
38	F	51	1998	pT2 pNX M0	TT	NP	Spor	90.80	3.3	+	—	31
39	F	68	1994	pT3 pN1b M0	ST, C LNP	Irrad	MEN 2a	39.00	11.9	−	—	78
40	M	35	1997	pT4 pN1b MX	NT, BS LND + C	Irrad	MEN 2a	891.00	23.5	−	—	38

BS = both sides; ST = subtotal thyroidectomy; RN = radionuclide (¹³¹I-MIBG) therapy; irrad = external irradiation; spor = sporadic; NT = near total thyroidectomy; LND = lymph node dissection; C = central; LNP = lymph node picking; patho = histology/cytology; radi = radiology; MEN 2a = multiple endocrine neoplasia type 2a; TT = total thyroidectomy; Sc = supraclavicular; ND = not determined; chemo = chemotherapy; MEN 2b = multiple endocrine neoplasia type 2b; NP = not performed; FMTC = familial MTC; medi = mediastinal.